These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23196212)

  • 61. Dynamic fMRI and EEG recordings during spike-wave seizures and generalized tonic-clonic seizures in WAG/Rij rats.
    Nersesyan H; Hyder F; Rothman DL; Blumenfeld H
    J Cereb Blood Flow Metab; 2004 Jun; 24(6):589-99. PubMed ID: 15181366
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Unsuccessful treatment of severe pyruvate carboxylase deficiency with triheptanoin.
    Breen C; White FJ; Scott CA; Heptinstall L; Walter JH; Jones SA; Morris AA
    Eur J Pediatr; 2014 Mar; 173(3):361-6. PubMed ID: 24114256
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Pharmacokinetics of Triheptanoin and Its Metabolites in Healthy Subjects and Patients With Long-Chain Fatty Acid Oxidation Disorders.
    Lee SK; Gupta M; Shi J; McKeever K
    Clin Pharmacol Drug Dev; 2021 Nov; 10(11):1325-1334. PubMed ID: 33789001
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dietary triheptanoin rescues oligodendrocyte loss, dysmyelination and motor function in the nur7 mouse model of Canavan disease.
    Francis JS; Markov V; Leone P
    J Inherit Metab Dis; 2014 May; 37(3):369-81. PubMed ID: 24288037
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dietary management and major clinical events in patients with long-chain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study.
    Vockley J; Longo N; Madden M; Dwyer L; Mu Y; Chen CY; Cataldo J
    Clin Nutr ESPEN; 2021 Feb; 41():293-298. PubMed ID: 33487279
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tridecanoin is anticonvulsant, antioxidant, and improves mitochondrial function.
    Tan KN; Carrasco-Pozo C; McDonald TS; Puchowicz M; Borges K
    J Cereb Blood Flow Metab; 2017 Jun; 37(6):2035-2048. PubMed ID: 27418037
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Triheptanoin, an odd-medium-chain triglyceride, impacts brain cognitive function in young and aged mice.
    da Rocha LS; Mendes CB; Silva JS; Alcides RLGF; Mendonça IP; Andrade-da-Costa BLS; Machado SS; Ximenes-da-Silva A
    Nutr Neurosci; 2024 Mar; 27(3):212-222. PubMed ID: 36809120
    [No Abstract]   [Full Text] [Related]  

  • 68. Maximum dose, safety, tolerability and ketonemia after triheptanoin in glucose transporter type 1 deficiency (G1D).
    Málaga I; Avila A; Primeaux S; Kallem RR; Roe CR; Putnam WC; Park JY; Shinnar S; Ahn C; Pascual JM
    Sci Rep; 2023 Mar; 13(1):3465. PubMed ID: 36859467
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pyruvate carboxylase deficiency type C; variable presentation and beneficial effect of triheptanoin.
    Bernhardt I; Van Dorp L; Dixon M; McSweeney M; Gan C; Baruteau J; Chakrapani A
    JIMD Rep; 2024 Jan; 65(1):10-16. PubMed ID: 38186850
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Exploring triheptanoin as treatment for short chain enoyl CoA hydratase deficiency.
    Engelstad K; Salazar R; Koenigsberger D; Stackowtiz E; Brodlie S; Brandabur M; De Vivo DC
    Ann Clin Transl Neurol; 2021 May; 8(5):1151-1157. PubMed ID: 33931985
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multiple molecular mechanisms for a single GABAA mutation in epilepsy.
    Reid CA; Kim T; Phillips AM; Low J; Berkovic SF; Luscher B; Petrou S
    Neurology; 2013 Mar; 80(11):1003-8. PubMed ID: 23408872
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement.
    Pascual JM; Liu P; Mao D; Kelly DI; Hernandez A; Sheng M; Good LB; Ma Q; Marin-Valencia I; Zhang X; Park JY; Hynan LS; Stavinoha P; Roe CR; Lu H
    JAMA Neurol; 2014 Oct; 71(10):1255-65. PubMed ID: 25110966
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Open-label long-term treatment of add-on triheptanoin in adults with drug-resistant epilepsy.
    Borges K; Kaul N; Germaine J; Carrasco-Pozo C; Kwan P; O'Brien TJ
    Epilepsia Open; 2020 Jun; 5(2):230-239. PubMed ID: 32524048
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Current Perspectives On The Role Of The Ketogenic Diet In Epilepsy Management.
    Goswami JN; Sharma S
    Neuropsychiatr Dis Treat; 2019; 15():3273-3285. PubMed ID: 31819454
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Triheptanoin alters [U-
    McDonald T; Hodson MP; Bederman I; Puchowicz M; Borges K
    J Cereb Blood Flow Metab; 2020 Mar; 40(3):678-691. PubMed ID: 30890077
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Randomized trial of add-on triheptanoin vs medium chain triglycerides in adults with refractory epilepsy.
    Borges K; Kaul N; Germaine J; Kwan P; O'Brien TJ
    Epilepsia Open; 2019 Mar; 4(1):153-163. PubMed ID: 30868125
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impairments in Oxidative Glucose Metabolism in Epilepsy and Metabolic Treatments Thereof.
    McDonald T; Puchowicz M; Borges K
    Front Cell Neurosci; 2018; 12():274. PubMed ID: 30233320
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.